Pharmaconex 2025 returns as the MEA region’s leading pharmaceutical platform, spotlighting Egypt’s expanding pharma landscape, innovative technologies, global networking, regulatory workshops, and a strong push towards sustainability.
Event Status: Upcoming
01 - 03 September 2025
|
Egypt International Exhibition Center, Cairo, Egypt 
According to a report from IQVIA, the Middle East and Africa (MEA) pharmaceutical market is poised for substantial growth, with projections indicating it will exceed $60 billion by 2028, driven by expanding local production and rising healthcare needs.
With over 400 million people living in Africa and the Middle East combined, the region’s pharmaceutical sector is becoming increasingly attractive to global investors.
$60 Billion+ by 2028 Pharmaceutical Market in the Middle East & Africa
Egypt’s Pharmaceutical Powerhouse: Egypt is a standout in the region, with:
The sector was valued at $4 billion in 2022 and is set to grow rapidly with Gypto Pharma City (the largest medicine city in the Middle East), capable of producing 150 million medicine packages annually. By 2030, Egypt aims to export $5 billion worth of pharmaceuticals, positioning itself as a regional leader.
Egypt is rapidly expanding its production capacity with ambitious goals to become the central hub for pharmaceutical production in Africa and the Middle East. With Gypto Pharma City and numerous private sector investments, the country is well-positioned to boost both local supply and export potential.
Increased Investment: The Egyptian government and private entities are committing significant resources to the pharmaceutical sector, making it a top priority in the country’s 2030 Vision for sustainable development. Egypt’s large, well-established pharmaceutical base makes it an attractive destination for international collaborations and investments.
The Pharmaconex 2024 Technical Conference brought together the invaluable insights, experience, and expertise of industry pioneers, government leaders, and academic experts from across Africa and beyond. It provided a strategic roadmap for navigating the evolving business landscape, innovative manufacturing trends, and the digitalization sweeping through the pharmaceutical industry.
In its 4th edition, the Cleanroom Conference was a pivotal event for industry professionals. Organized in partnership with the esteemed German Cleanroom Institute (DRRI), the conference featured an impressive lineup of speakers from both Europe and Egypt. Attendees engaged in critical discussions on the challenges faced in the cleanroom industry, explored best practices, and discovered the latest innovations driving the field forward.
Certified by the Egyptian Drug Authority (EDA), this two-day workshop focused on the intricacies of the Common Technical Document (CTD) and electronic CTD (eCTD). Participants were guided by Prof. Loice Kikwai, a seasoned expert from the US FDA, and learned how to manage submissions with a focus on validation and quality control.
This in-depth workshop, hosted by AGON in partnership with the Egyptian Drug Authority, provided a comprehensive look at pharmaceutical quality standards, from the basics of Good Manufacturing Practices (GMP) and Good Storage and Distribution Practices (GSDP) to advanced quality risk management techniques.
This highly focused workshop, led by Dr. Manar Antoune, explored the technical and regulatory complexities of technology transfer and process scale-up in pharmaceutical manufacturing. Attendees were equipped with practical strategies to manage these processes while maintaining compliance and product quality.
The Women in Pharma Networking Event in 2024, titled “Harmony in Leadership, Growth in Business”, was a dynamic platform for empowering women across the pharmaceutical industry. Organized by Informa Markets in collaboration with Women of Egypt, the event brought together over 16 influential speakers and more than 500 delegates from diverse sectors within the pharmaceutical and biopharmaceutical industries.
Matchmaking: Our exhibition application has been a vital tool in fostering business connections between exhibitors and visitors, enhancing the matchmaking program that has become integral to the Pharmaconex experience.
The application served as a platform for users to find, connect, and schedule meetings with the most relevant companies that align with their business needs prior to the show. The program is designed to maximize users’ time and facilitate impactful meetings, ensuring a productive and engaging experience.
Pharmaconex was thrilled to host over 235 VIP participants this year, featuring esteemed representatives from embassies, international organizations, and key government officials. Notable attendees from leading pharmaceutical companies further underscored Pharmaconex’s reputation as a premier platform for high-level engagement in the pharmaceutical sector.
We are committed at Pharmaconex to having a positive impact on people and the planet. We want to play a key role in helping the pharmaceutical manufacturing industry improve its own sustainability by connecting people with the networks and knowledge they need to help solve the big challenges of the future.
In 2024, dedicated conference talks were added to inspire sustainable practices for pharmaceutical sustainability, waste management, and sustainable packaging, in addition to sustainable development initiatives and practices for the pharmaceutical manufacturing process.
Pharmaconex makes a significant waste reduction by going digital:
